Advocates For Switching Birth Control Pill Face Social, Risk Obstacles
This article was originally published in The Tan Sheet
Executive Summary
A women's health advocacy group that hopes to meet with FDA within the next year to explore potentially switching oral contraceptives to OTC may be hard-pressed to find a pharmaceutical company interested in sponsoring such a venture